Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes.

Leelarathna, Lalantha, Thabit, Hood, Willinska, Malgorzata E, Bally, Lia, Mader, Julia K, Arnolds, Sabine, Benesch, Carsten, Pieber, Thomas R, Shah, Viral N, Carlson, Anders L, Bergenstal, Richard M, Evans, Mark L, Hovorka, Roman, AP@home04 and APCam11 consortia

Open source

DOI
10.17863/cam.48398
Published
2020
Container
Not recorded
Publisher
American Diabetes Association
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17863/cam.48398,
  title = {Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes.},
  author = {Leelarathna, Lalantha and Thabit, Hood and Willinska, Malgorzata E and Bally, Lia and Mader, Julia K and Arnolds, Sabine and Benesch, Carsten and Pieber, Thomas R and Shah, Viral N and Carlson, Anders L and Bergenstal, Richard M and Evans, Mark L and Hovorka, Roman and AP@home04 and APCam11 consortia},
  year = {2020},
  doi = {10.17863/cam.48398},
  url = {https://doi.org/10.17863/cam.48398}
}

RIS

TY  - JOUR
TI  - Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes.
AU  - Leelarathna, Lalantha
AU  - Thabit, Hood
AU  - Willinska, Malgorzata E
AU  - Bally, Lia
AU  - Mader, Julia K
AU  - Arnolds, Sabine
AU  - Benesch, Carsten
AU  - Pieber, Thomas R
AU  - Shah, Viral N
AU  - Carlson, Anders L
AU  - Bergenstal, Richard M
AU  - Evans, Mark L
AU  - Hovorka, Roman
AU  - AP@home04 and APCam11 consortia
PY  - 2020
DO  - 10.17863/cam.48398
UR  - https://doi.org/10.17863/cam.48398
ER  - 

APA

Lalantha, L., Hood, T., E, W. M., Lia, B., K, M. J., Sabine, A., Carsten, B., R, P. T., N, S. V., L, C. A., M, B. R., L, E. M., Roman, H., & consortia, A. A. A. (2020). Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes.. https://doi.org/10.17863/cam.48398

Source records